Epistem Limited

disease & therapeutic research models

Inflammatory Bowel Disease

GI Toxicity and Mucositis

Immune Cell Assays

Rheumatoid Arthritis

services

Gene Expression Analysis

Histology and IHC Services

Laser Capture Microdissection

Analytical Services

Plucked Hair Analysis

Announcements

NEWS: Epistem completes board line up and launches new NGS service
2018-11-28
Epistem Limited, the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments.…
NEWS: 10 Years GCLP Accreditation at Epistem
2019-01-11
We are pleased to announce the successful GCLP re-accreditation of our…
NEWS: Epistem completes management buyout
2018-06-12
Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management…

Spotlight On...

Redefining the practical utility of blood transcriptome biomarkers in …
Screening for IDB candidate genes using RNA sequencing of whole blood liquid biopsies taken from relatively large cohorts of both adult and pediatric…
Epithelial-mesenchymal transition in human prostate cancer demonstrates …
Cancer invasion and metastasis are driven by epithelial-to-mesenchymal transition (EMT). This study identifies an important link between EMT and…
Overexpression of miR-221 and miR-222 in the cancer stroma is associated with …
In this study the authors used laser capture microdissection to investigate the role of stromal miRNA in patients with metastatic cancer, aiming to…
Transcriptomic analysis of hepatocellular carcinoma reveals molecular features …
Hepatocellular carcinoma (HCC) is a common cause of cancer deaths with a particularly poor prognosis. A recent publication by Okrah et al.,…
The role of immunohistochemistry in patient stratification and personalised …
Not all patients respond well to treatment and drugs have failed in the clinic due to “all patient” designs. Immunohistochemistry (IHC)…

© 2018, 2019 Epistem Ltd.

site map | privacy policy | terms of use | contact us

Call us on +44 (0)161 850 7600 or email info@epistem.co.uk

Accelerating Drug Development with Innovative Services

This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this again